Ligand Pharmaceuticals
LGND
LGND
197 hedge funds and large institutions have $953M invested in Ligand Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 19 increasing their positions, 147 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
65.92% less ownership
Funds ownership: 153.04% → 87.12% (-66%)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
87% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 147
Holders
197
Holding in Top 10
1
Calls
$1.74M
Puts
$174K
Top Buyers
| 1 | +$7.86M | |
| 2 | +$7.49M | |
| 3 | +$3.43M | |
| 4 |
SG Americas Securities
New York
|
+$2.53M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$2.35M |
Top Sellers
| 1 | -$186M | |
| 2 | -$99.1M | |
| 3 | -$68.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$58.5M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$35.2M |